Lumida
/TPB
⌘K
Turning Point Brands Inc

Turning Point Brands Inc

TPB
$82.84USD↓-0.67%-0.56 today

MARKET CAP

1.6B

P/E (TTM)

22.1x

FWD P/E

30.7x

DAY RANGE

$82 – $85

52W RANGE

$66
$147

AI Summary

Stalk
Buy NowMedium

TPB is in an early Stage 1 consolidation after a sharp Q1 collapse, with 9/21 EMAs now rising and holding as support. The Bullish Pivot Point pattern confirms downside control has failed and structural repair is underway, while neutral OB/OS context and no exhaustion suggest readiness for an upside breakout. Medium-term asymmetry favors mean reversion higher, and short-term conditions align, making execution favorable now on a move above the base’s upper boundary.

  • ↑Q1 revenue $124.3M (+16.8% YoY) with modern oral sales up 167% (42% of total).
  • ↑Raised full-year modern oral sales guidance to $280–300M, highlighting strong momentum.
  • ↓Free cash flow was negative $27.4M in Q1 due to heavy marketing investment.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Turning Point Brands, Inc. (NYSE: TPB) operates predominantly within the nicotine consumption industry, specializing in modern oral nicotine products and legacy tobacco items. Its strong positioning in the evolving market for nicotine pouches, driven by changing consumer preferences, sets the company in the center of a lucrative category projected to exceed $50 billion. With a strategic focus on building brand recognition and distribution capabilities, Turning Point aims to capitalize on the generational shift towards smokeless nicotine alternatives.

Bull says

  • ↑Q1 revenue $124.3M (+16.8% YoY) with modern oral sales up 167% (42% of total).
  • ↑Raised full-year modern oral sales guidance to $280–300M, highlighting strong momentum.
  • ↑Adjusted EBITDA $25.9M (20.8% margin) demonstrates operational efficiency while scaling.
  • ↑Planning $80–105M in 2026 sales & marketing investments to expand distribution.
  • ↑High earnings yield and strong momentum factors support potential returns.
  • ↑Modern oral market projected >$50B; TPB targets $10B revenue by decade end.

Bear says

  • ↓Free cash flow was negative $27.4M in Q1 due to heavy marketing investment.
  • ↓SG&A expenses rose to $55.8M, squeezing profit margins amid brand building.
  • ↓Analysts are lowering estimates; negative revisions signal weakening sentiment.
  • ↓High valuation concerns: stock appears overvalued relative to book value.
  • ↓Intense competition and PMTA regulatory hurdles could delay expansion.
  • ↓External market volatility may pressure discretionary nicotine demand and stock.

Investment themes with TPB

Tobacco↑ +0.22%

Producers and distributors of tobacco products

BTI · TPB · JAPAY

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-11-2026neutral

Transcript signals

Bull points

  • Our strategy is to build demand across both online and retail channels, with retail expansion as the key lever to scale the business.
  • In the first quarter, we made progress against that plan. We secured new wins across critical top chain convenience stores that will expand distribution across our portfolio.
  • We believe our brand credibility, market performance, and ongoing marketing support were important drivers of those wins.

Bear points

  • Legacy Stoker's brand net revenue decreased 3.5% year-over-year to $36 million for the quarter, driven by continued share growth in MSD that was partially offset by anticipated declines in loose leaf.
  • First quarter free cash flow was negative $27.4 million, reflective of our investments, in trade and brand marketing programs, as well as working capital in U.S. manufacturing CapEx.
  • Legacy Stoker's brand net revenue decreased 3.5% year-over-year to $36 million for the quarter, driven by continued share growth in MSD that was partially offset by anticipated declines in loose leaf.
Read full transcript analysis ›